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Introduction. B. cepacia complex have emerged as an impor-
tant opportunistic pathogen in hospitalized and immunocompro-
mised patients. Small hospital outbreaks are frequent and are 
usually due to a single contaminated environmental source. In 
this study we were going to investigate the role of B.cepacia 
complex in those patients suspected to involve with cystic fibro-
sis and evaluate responsible types in Masih Daneshvary Hos-
pital.
Methods. One hundred specimens were collected from all admit-
ted patients who were suspected to cystic fibrosis to Masih 
Daneshvary hospital during one year April 2011 till end of March 
2012. All were culture and identified standard procedure. All 
samples were checked by API system (API20NE) and by specific 
PCR method for genus Bulkhorderia and Bcc as well. Identified 
strains were finally tested by PFGE system to identifying specific 
involving pulse-types.
Results. Isolation and identification methods revealed 5 speci-
mens were B.cepasia, The frequency of the cystic fibrosis detected 
at this study was lower than other similar study previously 
reported. All these isolates showed similar pattern by PFGE 
standard protocol that may have spread from a single source and 
could not be attributed to cross infections from patient to patients.
Discussion. Application of PFGE and identification of pulse-type 
is a potential tool to enhance the investigation of apparent noso-
comial outbreaks of B.cepacia. However it needs to be adjusted 
with environmental findings. Implementation of educational pro-
grams and adherence to infection control policies are obviously 
the main element for complete elimination of an outbreak.
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Summary
Introduction
The Burkholderia cepacia complex (BCC) is a group of 
strictly aerobic, gram negative BCC. also known as ‘‘B. 
cepacia like bacteria’’. It currently divided into 17 spe-
cies that mainly affect people with underlying disease 
such as cystic fibrosis or granulomatous disease, and 
show antimicrobial resistant to many of antibiotics [1-3].
The term ‘‘complex’’ emerged in the literature at the 
beginning of the genomic era associated to taxonomy 
and grouping organisms that belong to different species 
but exhibited similar patterns according to their morpho-
logical, physiological and/or other phenotypic features. 
DNA–DNA hybridization with 70% and high identity 
on 16S rRNA gene sequences [4].
Presently, the BCC includes 17 species: B. ambifaria, 
B. anthina, B. arboris, B. cepacia, B. cenocepacia, B. 
contaminans, B. diffusa, B. dolosa, B. lata, B. latens, B. 
metallica, B. multivorans, B. pyrrocinia, B. seminalis, 
B. stabilis, B. ubonensis, B. vietnamiensis. Among these 
organisms some authors have detected B. cepacia more 
frequently than the rest especially in non-CF patients [5].
Bcc is among the pathogens most frequently reported 
outbreaks and has been described in several healthcare 
centers around the world [6-13]. These organisms have 
also emerged as an important cause of morbidity and 
mortality in hospitalized patients because of high rate of 
antibiotic resistance [14]. Therefore, fast detection and 
elimination of the source of such these outbreaks is the 
great importance in guiding infection control measures 
and preventing additional cause of infections especially 
at Cystic Fibrosis centers.
The aim of this study was first isolation and identifica-
tion of Bcc and then to perform molecular typing by 
pulsed-field gel electrophoresis (PFGE) in order to eval-
uate the epidemiology of this pathogen in CF patients at 
Masih Daneshvary Hospital.
Methods
Sampling: One hundred specimens were collected from 
all admitted patients who were suspected to cystic fibro-
sis to Masih Daneshvary hospital during one year April 
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2011 till end of March 2012. Isolation and Identifica-
tion: Bacterial identification was performed after cultur-
ing in BHI broth. One loop broth was then of transferred 
to blood agar after overnight incubation. Isolates were 
identified use standard identification tests and with AP-
I20NE system as well [15]. After species identification, 
isolates were stored at -20 oC as suspensions in 10% 
skim milk solution containing 10% glycerol.
PCR Methods: Microbial suspension was prepared for 
each isolated specimens and extracted use of QIAamp 
DNA Mini Kit (QIAGEN GmbH, Hilden, Germany). 
The purity of all the extracted specimens was determined 
by measuring the optical density at the wavelengths of 
260 and 280 nm. Primer pair sequences was order based 
on the Lynch’s report (et al. 2008) [16]. He reported two 
set of Primer pairs one detecting Bulkhurderia species 
and the second specific for the BCC (Tab. I).
20 μl mixtures were prepared use of 200 μM of dNTP, 1.5 
mM MgCl2,50 pg of each primers, 2U of taq polymerase, 
1x PCR buffer and different concentration of each primer. 
The PCR were performed on Eppendorf thermal cyclers 
(Mastercycler Gradient) by following program: 96oC for 
4 min, then 35 cycles at 96oC, 59oC, and 72oC each for 
1 min, at the end 2 min at 59oC. PCR products were ana-
lyzed on 2% agarose gel with100 base pair ladder.
Genotyping: DNA polymorphisms of all isolates were 
evaluated by pulsedfield gel electrophoresis (PFGE) 
with SpeI (Boehringer Mannheim Biochemicals), as de-
scribed elsewhere. 20 DNA banding patterns were com-
pared by standard DNA marker interpreted by visual 
inspection. 
PFGE was briefly performed as follows: bacterial sus-
pension was prepared in a buffer (100 mmol l-1Tris, 
100 mmol l-1 EDTA, pH 8.0) and adjusted to absorb-
ance values of 0.8 - 1.0 at a wavelength of 610 nm after 
which plugs were prepared with SeaKem Gold agarose 
(Lonza, Rockland, ME, USA) and proteinase K. Bac-
terial plugs were lysed (50 mmol l-1Tris, 50 mmol l-1 
EDTA, 1% sarcosine, and 0.5 mg of proteinase K,pH 
8.0) and washed after which digested with forty units of 
Spe I restriction enzyme (Fermentase). DNA molecular 
weight size marker was prepared by XbaI digestion of 
Salmonella enterica serotype Braenderup H9812 plugs. 
CHEF Mapper XA System (Bio-Rad) was applied for 
electrophoresis.
Results
Isolation and applied identification testes revealed 5 
specimens were Burkholderia cepacia. PCR results also 
confirmed in these specimens (Tab. II and Fig. 1). The 
frequency of the cystic fibrosis detected at this study was 
5%. It is obviously different at variously reports. Leite 
and coworkers studied a total of 244 CF patients from 
HCPA and observed a prevalence rate of BCC of 10.6%. 
BCC accounted for most BCC isolates in 244 examined 
specimens [17].
PFGE results: PFGE were performed by the standard 
procedures use of SpeI Restriction enzyme and provide 
one unique electrophoresis pattern (Fig. 2) meaning 
similar type involving in those patients suffering cystic 
fibrosis due to Burkholderia cepacia. Use of XbaI also 
revealed similar pattern among these 5 isolated organ-
isms. The presence uniform pattern and similar pulse-
type in all these identified B.cepacia was concluded just 
by visual inspection use of standard DNA marker since 
the system have set up recently and BioNumerics had 
not been delivered to the molecular lab on running date 
of experiment. The pattern of each sample was carefully 
analyzed and experiment repeated once more, although 
it was necessary to interpret these results by computer 
software such as gel compare or BioNumerics and draw-
ing related dendrogram.
Tab. I. primer sequence used in this study. 
Trarget Primer Sequence Species Product size
recA BCC(F) ATgACCAATCCgACCgATCTCAA
All 429(bp)
BCC(r) TCAgTgCTTgCgITNIgggCAgTT
recA BKF(F) ggCNgAAgACgTCTACCgg
BCC (group K) 117(bp)
BKF(r) TCgAAgTTgCTgCgCgAC
Tab. II. ApI results for isolated specimens. All 5 isolated specimens had similar reaction to the standard strains by applied biochemical tests.
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Discussion
In 2001, Agodi (et al. 2001) indicated a prevalence of 
Bcc infection of 9.5% in a study performed in four Ital-
ian CF Centers  [18]. The frequency rate is obviously 
different in various reports. The possibility of patient-
to-patient transfer of B. cepacia in the CF community 
has always been one of great concerns. Because patients 
colonized with Bcc may remain colonized for a long pe-
riods of time. In some patients, however, Bcc was not 
isolated for several years and then their first strain reap-
peared up to 10 years later. In some of these patients, it 
cannot be excluded that reacquisition from the environ-
ment occurred.
PFGE has the excessively high discriminatory and re-
producible for the epidemiological study of BCC com-
parison with other typing method  [19]. Based on the 
generated PFGE results by SpeI restriction enzyme all 
specimens had analogous PFGE pattern with 100% ge-
netic similarity in this study.
It is possible that the observed infections may have 
spread from a single source since having identical PFGE 
pattern. This suggested hypothesis was supported by the 
isolation results because no other Burkholderia species 
was identified during the study over a period from April 
2011 till end of March 2012. The unusual species dis-
tribution may be attributed to environmental sources be-
sides to cross infections from patient to patients, although 
having similar pattern. Several epidemiological studies 
have shown most cases of BCC infection transmitted be-
tween CF patients [20]. However, occasionally detected 
B.cepacia distribution during one year of study may rep-
resent the acquisition from the environment as well as 
other sources cross infections from patient to patients.
It is frequently reported B.cepacia has high transmissi-
bility rate and are the responsible microorganism for the 
mostly nosocomial infections among BCC. B.cepacia in-
fection may result a significant illness, particularly in 
the cystic fibrosis patients, where patients are at greater 
risk of nosocomial infection due to their underlying ill-
ness. Therefore this finding suggests the importance of 
adequate patient follow-up in those hospitals that are the 
referral for CF centers.
Conclusion
Application of PFGE and identification of pulse-type is 
a potential tool to enhance the investigation of apparent 
nosocomial outbreaks of B.cepacia. However it needs to 
be adjusted with environmental findings. Implementa-
tion of educational programs and adherence to infection 
control policies are obviously the main element for com-
plete elimination of an outbreak.
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